REG - MicroSalt PLC - Trading Update

MicroSaltAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260112:nRSL4183Oa&default-theme=true

RNS Number : 4183O  MicroSalt PLC  12 January 2026

12 January 2026

MicroSalt Plc

 

("MicroSalt" or the "Company")

 

Trading Update

 

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt
with approximately 50% less sodium, is pleased to provide the following
trading update and continuing advancement of its B2B bulk business for the
financial year ended 31 December 2025 ("FY25").

 

The Group is delighted to announce that unaudited sales for FY25 exceeded the
Board's original revenue expectations of $2.0 million, increasing by 287%
year-on-year to $2.14 million (2024: $745k).

 

The Company continues to project 2026 sales to total $7.0 million based on
in-hand volume estimations and its current customer base, rising to more than
$15.0 million in 2027.

 

As outlined in the Company's Trading Update on 14 November 2025, MicroSalt has
witnessed increased North America volume projections throughout 2025 from
Customer 3, one of the world's largest food, soft drink and snack
manufacturers. The increased volume projections included a new product that is
due to commence in Q2 2026. The Company's first bulk order for this product
has been delivered for a specific end retailer of Customer 3; in addition,
further similar orders have been received on a broadly monthly basis since, in
line with management expectations.

 

Rick Guiney, CEO of MicroSalt, commented:

"We are immensely proud to have exceeded Board expectations in 2025,
delivering revenue growth of 287% compared to 2024. This performance is a
clear testament to the strength of our offering, the versatility of
MicroSalt's applications, and the successful execution of our strategy to
build a sustainable and profitable organisation. Importantly, it reinforces
our commitment to delivering healthier food alternatives globally while
driving revenue growth and long-term value for our shareholders. Our final
2025 healthy servings totalled 830,735,462, providing clear evidence that
MicroSalt is successfully delivering on its mission of enabling healthier
foods by helping to reduce excess sodium consumption.

 

"We look forward to continuing our close collaboration with existing partners
as we deepen relationships and expand our global reach. At the same time, we
remain focused on establishing new partnerships that will support our next
phase of growth. As we look ahead, we are confident in our ability to build on
this momentum and continue strengthening the business for the benefit of both
our customers and shareholders."

 

Enquiries:

 

 MicroSalt plc                                    info@microsaltinc.com
 Rick Guiney (CEO)

 Zeus (Nominated Adviser and Broker)              +44 (0)20 3829 5000
 David Foreman / James Edis (Investment Banking)

 Gracechurch Group (Financial PR)                 +44 (0)20 4582 3500
 Heather Armstrong, Alexis Gore, Rebecca Scott

 

 

About MicroSalt

 

MicroSalt is disrupting the global salt market with its patented,
full-flavour, low-sodium salt designed for both food manufacturers and
consumers. Using proprietary micron-sized particles, MicroSalt delivers the
same salty taste as traditional salt with approximately 50% less sodium,
offering a scalable solution to one of the world's most pressing health
challenges. Year to date through 2025, MicroSalt has contributed to more than
634M servings made healthier.

 

Excess sodium consumption is a leading contributor to cardiovascular disease,
the world's number one cause of death. The World Health Organisation has
targeted a 30% reduction in global sodium intake by 2025, a shift projected to
save seven million lives by 2030. The economic case is equally compelling: in
the UK alone, cardiovascular disease costs £19 billion annually, and reducing
average daily salt intake by just one gram could save over 4,000 lives and
£288 million each year.

 

Operational since 2018, MicroSalt has established a defensible IP portfolio,
holding a granted US patent and 14 pending applications worldwide. These
protections create significant barriers to entry in a market expected to grow
exponentially as regulation and consumer demand accelerate.

 

MicroSalt is ideally positioned for scale and market leadership, with clear
pathways into food manufacturing, consumer channels, and ultimately the
broader £10+ billion global salt market. MicroSalt is more than a healthier
alternative-it is a disruptive, category-defining solution poised to deliver
significant commercial and societal impact.

 

For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) or follow on X @microSaltPLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTGZGMMDMLGVZM



            Copyright 2019 Regulatory News Service, all rights reserved